Gamma Biosciences

Gamma Biosciences is a private investment firm dedicated to advancing the development and production of biopharmaceuticals. The firm collaborates with small to mid-sized companies to provide capital and expertise, aiming to accelerate the growth of innovative therapies.

Established in 2019 in partnership with KKR & Co., Gamma Biosciences has invested nearly $300 million into early and mid-stage businesses within the biomanufacturing value chain. The firm's portfolio includes Astrea Bioseparations, a UK-based leader in affinity chromatography and process purification, and Univercells, a Belgium-based company specializing in biomanufacturing equipment.

Gamma Biosciences leverages its collective industry experience and network to support companies in the biopharmaceutical sector, focusing on next-generation bioprocessing technologies for advanced biologic therapies. The firm is headquartered in Menlo Park, California, and operates in the United States, United Kingdom, and Belgium.